Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Selecta Biosciences Q2 EPS $0.00, Sales $19.66M Beat $6.24M Estimate

Selecta Biosciences (NASDAQ:SELB) reported quarterly sales of $19.66 million which beat the analyst consensus estimate of $6.24 million by 215.11 percent.
byBill Haddad
August 12, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

Selecta Biosciences (NASDAQ:SELB) reported quarterly sales of $19.66 million which beat the analyst consensus estimate of $6.24 million by 215.11 percent.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0